NASDAQ:CMPX Compass Therapeutics (CMPX) News Today $1.96 +0.09 (+4.81%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$1.86▼$1.9850-Day Range$1.87▼$2.9352-Week Range$1.81▼$5.65Volume340,830 shsAverage Volume185,588 shsMarket Capitalization$249.82 millionP/E RatioN/ADividend YieldN/APrice Target$9.05 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHere's Why We're Not Too Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Situationfinance.yahoo.com - August 24 at 9:05 AMHC Wainwright & Co. Reiterates Compass Therapeutics (CMPX) Buy Recommendationmsn.com - August 3 at 10:23 PMCompass Therapeutics GAAP EPS of -$0.09msn.com - August 3 at 12:21 PMCompass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 3 at 12:21 PMCompass Therapeutics added to Russell indexesmsn.com - June 22 at 6:52 PMCompass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexesfinance.yahoo.com - June 22 at 6:52 PMCompass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexesfinance.yahoo.com - June 22 at 6:52 PMCitigroup Inc. Boosts Position in Compass Therapeutics, Inc. (NASDAQ:CMPX)marketbeat.com - June 4 at 4:49 AMCompass Therapeutics to Participate in Upcoming Investor Eventsfinance.yahoo.com - June 1 at 2:33 PMCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Consensus Rating of "Buy" from Brokeragesmarketbeat.com - May 31 at 3:34 AMSVB Securities Keeps Their Buy Rating on Compass Therapeutics (CMPX)markets.businessinsider.com - May 10 at 12:32 AMCompass Therapeutics, Inc. (NASDAQ:CMPX) Forecasted to Post FY2027 Earnings of $1.94 Per Sharemarketbeat.com - May 8 at 4:50 AMCompass Therapeutics: Q1 Earnings Insightsmsn.com - May 4 at 1:48 PMCompass Therapeutics Reports First Quarter Financial Results and Provides Corporate Updatefinance.yahoo.com - May 4 at 8:48 AMCompass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQfinance.yahoo.com - April 26 at 9:37 AMFrequently Asked Questions: U.S. News College Compassusnews.com - April 25 at 9:41 AMCompass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Daysfinance.yahoo.com - April 19 at 8:55 AMWith 55% ownership of the shares, Compass Therapeutics, Inc. (NASDAQ:CMPX) is heavily dominated by institutional ownersfinance.yahoo.com - April 13 at 8:06 AMCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Recommendation of "Buy" from Analystsmarketbeat.com - April 11 at 4:19 AMShort Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Rises By 17.7%marketbeat.com - March 31 at 8:15 AMCompass Therapeutics to Participate in the Cantor Fitzgerald Future of Oncology Symposiumfinance.yahoo.com - March 28 at 8:43 AMCompass Therapeutics GAAP EPS of -$0.10seekingalpha.com - March 17 at 1:01 PMWe're Hopeful That Compass Therapeutics (NASDAQ:CMPX) Will Use Its Cash Wiselyfinance.yahoo.com - March 17 at 8:01 AMCompass Therapeutics, Inc. Forecasted to Earn Q1 2023 Earnings of ($0.11) Per Share (NASDAQ:CMPX)marketbeat.com - March 17 at 6:20 AMCompass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Recommendation of "Buy" by Analystsmarketbeat.com - March 17 at 3:07 AMCompass Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updatefinance.yahoo.com - March 15 at 9:41 AMCompass Therapeutics, Inc. (NASDAQ:CMPX) CEO Thomas J. Schuetz Acquires 10,000 Sharesmarketbeat.com - March 10 at 4:53 PM1,100,399 Shares in Compass Therapeutics, Inc. (NASDAQ:CMPX) Purchased by Eventide Asset Management LLCmarketbeat.com - March 3 at 11:03 AMCMPX Compass Therapeutics, Inc.seekingalpha.com - February 15 at 11:20 PMCompass Therapeutics to Participate in the SVB Securities Global Biopharma Conferencefinance.yahoo.com - February 2 at 12:50 PMBenzinga's Top Ratings Upgrades, Downgrades For January 27, 2023msn.com - January 27 at 1:10 PMExpert Ratings for Compass Therapeuticsmarkets.businessinsider.com - January 27 at 1:10 PMCo-Founder Thomas Schuetz Just Bought A Handful Of Shares In Compass Therapeutics, Inc. (NASDAQ:CMPX)yahoo.com - January 26 at 10:13 AMCompass Therapeutics added to Wedbush Best Ideas List on lead cancer candidatemsn.com - January 24 at 3:17 PMAnalysts Set Expectations for Compass Therapeutics, Inc.'s FY2027 Earnings (NASDAQ:CMPX)marketbeat.com - January 20 at 9:46 AMCompass Therapeutics Announces that the Phase 2 Data of CTX-009 in Combination with Paclitaxel in Patients with Biliary Tract Cancers (BTC) will be Presented at the ASCO GI Cancers Symposium on January 20, 2023finance.yahoo.com - January 19 at 10:16 PMCompass Therapeutics, Inc. (NASDAQ:CMPX) Sees Large Increase in Short Interestmarketbeat.com - January 18 at 4:10 AMCompass Therapeutics Announces First Patient Dosed in the Phase 2 U.S. Study of CTX-009 in Patients with Metastatic Colorectal Cancerfinance.yahoo.com - January 6 at 8:55 AMCompass Therapeutics Announces Presentation of Updated Results from the Ongoing Phase 2 study of CTX-009 in Biliary Tract Cancer (BTC) at the 2023 ASCO GI Cancers Symposium January 19-21finance.yahoo.com - December 15 at 12:35 PMShort Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Declines By 17.1%marketbeat.com - December 4 at 9:07 PMCompass Therapeutics Announces First Patient Dosed in the Phase 1b CTX-471 Combination Trial with KEYTRUDA® (pembrolizumab)finance.yahoo.com - December 1 at 6:51 PMCompass Therapeutics (NASDAQ:CMPX) Stock Price Down 9.2% After Insider Sellingmarketbeat.com - November 30 at 1:16 AMCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of "Buy" from Analystsmarketbeat.com - November 28 at 3:12 AMOne Compass Therapeutics, Inc. (NASDAQ:CMPX) insider upped their stake by 0.6% in the previous yearfinance.yahoo.com - November 27 at 8:42 AMVered Bisker-Leib Sells 14,929 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) Stockmarketbeat.com - November 25 at 6:37 PMCompass Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conferencefinance.yahoo.com - November 22 at 7:32 PMCompass Therapeutics (NASDAQ:CMPX) PT Raised to $9.00 at LADENBURG THALM/SH SHmarketbeat.com - November 16 at 5:18 PMFY2022 Earnings Forecast for Compass Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:CMPX)marketbeat.com - November 14 at 2:29 AMCompass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Down 21.9% in Octobermarketbeat.com - November 13 at 4:43 PMCompass Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 9 at 9:08 AM Get Compass Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPX and its competitors with MarketBeat's FREE daily newsletter. Email Address CMPX Media Mentions By Week CMPX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPX News Sentiment▼0.000.52▲Average Medical News Sentiment CMPX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPX Articles This Week▼01▲CMPX Articles Average Week Get Compass Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALVR News ZURA News VIGL News DBVT News SCLX News FATE News STRO News MESO News ABOS News IPHA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:CMPX) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.